Our findings indicate that the presence of strong and diffuse TRPS1 expression may lean towards a diagnosis of AFX over angiosarcoma or melanoma, provided it is supported by other commonly used discriminatory immunohistochemical markers like ERG and SOX10. This evidence concerns the gene ERG and angiosarcoma.